Cleveland Clinic, RIKEN and IBM Team Advance to Finals for 2026 ACM Gordon Bell Prize
A research team from Cleveland Clinic, RIKEN, and IBM became a finalist for the ACM Gordon Bell Prize. The entry describes simulating a 12,635-atom protein using quantum-centric supercomputing methods. The work combines IBM Heron processors with classical supercomputers. No new developer tools, software releases, or open-source artifacts are provided for immediate use.
